サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：皮膚科のCROの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測
市場調査レポート
商品コード
1421119

皮膚科のCROの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測

Global Dermatology CRO Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日: | 発行: Value Market Research | ページ情報: 英文 181 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
皮膚科のCROの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測
出版日: 2024年01月01日
発行: Value Market Research
ページ情報: 英文 181 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

皮膚科のCRO市場の世界需要は、2023年の56億7,000万米ドルから2032年にはほぼ106億5,000万米ドルの市場規模に達すると推定され、調査期間2024年～2032年のCAGRは7.25%です。

皮膚科のCROはDermatology Contract Research Organizationの略です。CROは製薬、バイオテクノロジー、医療機器業界に調査サービスを提供する医薬品開発業務受託機関です。皮膚科領域では、皮膚疾患や病態に関連した臨床試験や調査の実施を専門としています。製薬会社や研究者がデータを収集し、試験を実施し、新しい皮膚科学的治療法や治療法の開発に関連する規制プロセスをナビゲートする上で重要な役割を果たしています。

市場力学

皮膚科のCRO（医薬品開発業務受託機関）市場は、いくつかの重要な要因によって支えられています。皮膚疾患の有病率の増加は、革新的な治療法への需要に拍車をかけ、皮膚科学の研究開発活動を促進しています。技術の進歩と個別化医療へのシフトは、この分野における専門的研究サービスの必要性をさらに高めています。製薬会社は臨床試験活動をCROに委託することが増えており、CROの専門知識とインフラの恩恵を受けながら、コアコンピタンスに集中するようになっています。皮膚科研究の複雑性と進化する規制ガイドラインは、これらの課題を解決するためにCROサービスへの依存を高める一因となっています。製薬業界がアウトソーシングを優先し続け、皮膚科学研究がより複雑になるにつれ、皮膚科学CRO市場は持続的な成長を遂げ、様々な皮膚疾患に対する新しい治療法や治療法の開発を進める上で重要な役割を果たしています。

調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、皮膚科クロの世界市場における各セグメントを包括的に評価することもできます。皮膚科cro業界の成長と動向は、この研究に全体的なアプローチを提供します。

市場セグメンテーション

本セクションでは、国別および地域別のセグメントに関する詳細なデータを提供することで、戦略担当者がそれぞれの製品またはサービスのターゲット層を特定し、今後のビジネスチャンスに役立てることができます。

地域分析

本セクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおける皮膚科のCRO市場の現在および将来の需要を明らかにする地域展望を取り上げます。さらに、著名な全地域における個々のアプリケーションセグメントの需要・推定・予測にも焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 皮膚科のCRO-業界分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 皮膚科のCROの世界市場分析：タイプ別

  • タイプ別概要
  • 実績データと予測データ
  • タイプ別分析
  • 創薬（ターゲット検証、リード同定、リード最適化）
  • 前臨床
  • 臨床（フェーズi、フェーズII、フェーズIII、フェーズIV）

第6章 皮膚科のCROの世界市場分析：サービス別

  • サービス別概要
  • 実績データと予測データ
  • サービス別分析
  • プロジェクト管理/臨床供給管理
  • データ管理
  • 薬事/メディカルアフェアーズ
  • メディカルライティング
  • 臨床モニタリング
  • 品質管理/保証
  • バイオ統計
  • 治験責任医師への支払い
  • 臨床検査
  • 患者および施設募集
  • テクノロジー
  • その他

第7章 皮膚科のCROの世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋地域売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋地域：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他アジア太平洋地域
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ

第8章 皮膚科領域における競合情勢

  • 皮膚科領域の市場競争
  • 提携・協力・合意
  • 合併・買収
  • 新製品の上市
  • その他の開発

第9章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • IQVIA Inc.
  • Labcorp Drug Development
  • Pharmaceutical Product Development LLC（PPD）（Thermo Fisher Scientific Inc.）
  • Parexel International Corp.
  • Charles River Laboratories
  • Icon PLC
  • Medidata
  • Syneos Health
  • Pharmaron
  • ragen Life Sciences Ltd.
  • Wuxi AppTec
  • MEDPACE
  • CTI Clinical Trial & Consulting
  • Bioskin
  • Proinnovera GmbH
  • Biorasi LLC
  • Javara
  • TFS
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Type (USD MN)
  • Drug Discovery (Target Validation, Lead Identification, Lead optimization) Market Sales by Geography (USD MN)
  • Preclinical Market Sales by Geography (USD MN)
  • Clinical (Phase I, Phase II, Phase III, Phase IV) Market Sales by Geography (USD MN)
  • Analysis Market by Service (USD MN)
  • Project Management/Clinical Supply Management Market Sales by Geography (USD MN)
  • Data Management Market Sales by Geography (USD MN)
  • Regulatory/Medical Affairs Market Sales by Geography (USD MN)
  • Medical Writing Market Sales by Geography (USD MN)
  • Clinical Monitoring Market Sales by Geography (USD MN)
  • Quality Management/Assurance Market Sales by Geography (USD MN)
  • Bio-statistics Market Sales by Geography (USD MN)
  • Investigator Payments Market Sales by Geography (USD MN)
  • Laboratory Market Sales by Geography (USD MN)
  • Patient and Site Recruitment Market Sales by Geography (USD MN)
  • Technology Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Dermatology Cro Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Dermatology Cro Report
  • Market Research Process
  • Market Research Methodology
  • Global Dermatology Cro Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Service
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Type (USD MN)
  • Drug Discovery (Target Validation, Lead Identification, Lead optimization) Market Sales by Geography (USD MN)
  • Preclinical Market Sales by Geography (USD MN)
  • Clinical (Phase I, Phase II, Phase III, Phase IV) Market Sales by Geography (USD MN)
  • Global Market Analysis by Service (USD MN)
  • Project Management/Clinical Supply Management Market Sales by Geography (USD MN)
  • Data Management Market Sales by Geography (USD MN)
  • Regulatory/Medical Affairs Market Sales by Geography (USD MN)
  • Medical Writing Market Sales by Geography (USD MN)
  • Clinical Monitoring Market Sales by Geography (USD MN)
  • Quality Management/Assurance Market Sales by Geography (USD MN)
  • Bio-statistics Market Sales by Geography (USD MN)
  • Investigator Payments Market Sales by Geography (USD MN)
  • Laboratory Market Sales by Geography (USD MN)
  • Patient and Site Recruitment Market Sales by Geography (USD MN)
  • Technology Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR112113390

The global demand for Dermatology CRO Market is presumed to reach the market size of nearly USD 10.65 BN by 2032 from USD 5.67 BN in 2023 with a CAGR of 7.25% under the study period 2024 - 2032.

Dermatology CRO stands for Dermatology Contract Research Organization. CROs are companies that provide research services to the pharmaceutical, biotechnology, and medical device industries. In the context of dermatology, these organizations specialize in conducting clinical trials and research related to skin disorders and conditions. They play a crucial role in helping pharmaceutical companies and researchers gather data, conduct trials, and navigate the regulatory processes associated with developing new dermatological treatments or therapies.

MARKET DYNAMICS

The Dermatology Contract Research Organization (CRO) market is propelled by several key factors. The rising prevalence of skin disorders has spurred the demand for innovative treatments, driving research and development activities in dermatology. Advancements in technology and the shift towards personalized medicine have further intensified the need for specialized research services in this field. Pharmaceutical companies increasingly outsource clinical trial activities to CROs, benefiting from their expertise and infrastructure while focusing on core competencies. The complexity of dermatology research and evolving regulatory guidelines contribute to the growing reliance on CRO services to navigate these challenges. As the pharmaceutical industry continues to prioritize outsourcing and as dermatological research becomes more intricate, the dermatology CRO market experiences sustained growth, playing a crucial role in advancing the development of new therapies and treatments for various skin conditions.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of dermatology cro. The growth and trends of dermatology cro industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the dermatology cro market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • Drug Discovery (Target Validation, Lead Identification, Lead Optimization)
  • Preclinical
  • Clinical (Phase I, Phase Ii, Phase Iii, Phase Iv)

By Service

  • Project Management/Clinical Supply Management
  • Data Management
  • Regulatory/Medical Affairs
  • Medical Writing
  • Clinical Monitoring
  • Quality Management/Assurance
  • Bio-Statistics
  • Investigator Payments
  • Laboratory
  • Patient And Site Recruitment
  • Technology
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Dermatology CRO market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Dermatology CRO market include IQVIA Inc., Labcorp Drug Development, Pharmaceutical Product Development, LLC (PPD) (Thermo Fisher Scientific Inc.), Parexel International Corp., Charles River Laboratories, Icon, Plc, Medidata, Syneos Health, Pharmaron, ragen Life Sciences Ltd., Wuxi AppTec, MEDPACE, CTI Clinical Trial & Consulting, Bioskin, Proinnovera GmbH, Biorasi, LLC, Javara, TFS. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . DERMATOLOGY CRO - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Service
    • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL DERMATOLOGY CRO MARKET ANALYSIS BY TYPE

  • 5.1 Overview by Type
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Type
  • 5.4 Drug Discovery (Target Validation, Lead Identification, Lead optimization) Historic and Forecast Sales by Regions
  • 5.5 Preclinical Historic and Forecast Sales by Regions
  • 5.6 Clinical (Phase I, Phase II, Phase III, Phase IV) Historic and Forecast Sales by Regions

6 . GLOBAL DERMATOLOGY CRO MARKET ANALYSIS BY SERVICE

  • 6.1 Overview by Service
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Service
  • 6.4 Project Management/Clinical Supply Management Historic and Forecast Sales by Regions
  • 6.5 Data Management Historic and Forecast Sales by Regions
  • 6.6 Regulatory/Medical Affairs Historic and Forecast Sales by Regions
  • 6.7 Medical Writing Historic and Forecast Sales by Regions
  • 6.8 Clinical Monitoring Historic and Forecast Sales by Regions
  • 6.9 Quality Management/Assurance Historic and Forecast Sales by Regions
  • 6.10. Bio-statistics Historic and Forecast Sales by Regions
  • 6.11 Investigator Payments Historic and Forecast Sales by Regions
  • 6.12 Laboratory Historic and Forecast Sales by Regions
  • 6.13 Patient and Site Recruitment Historic and Forecast Sales by Regions
  • 6.14 Technology Historic and Forecast Sales by Regions
  • 6.15 Others Historic and Forecast Sales by Regions

7 . GLOBAL DERMATOLOGY CRO MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2. North America By Segment Sales Analysis
    • 7.3.3. North America By Country Sales Analysis
    • 7.3.4. United State Sales Analysis
    • 7.3.5. Canada Sales Analysis
    • 7.3.6. Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2. Europe by Segment Sales Analysis
    • 7.4.3. Europe by Country Sales Analysis
    • 7.4.4. United Kingdom Sales Analysis
    • 7.4.5. France Sales Analysis
    • 7.4.6. Germany Sales Analysis
    • 7.4.7. Italy Sales Analysis
    • 7.4.8. Russia Sales Analysis
    • 7.4.9. Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2. Asia Pacific by Segment Sales Analysis
    • 7.5.3. Asia Pacific by Country Sales Analysis
    • 7.5.4. China Sales Analysis
    • 7.5.5. India Sales Analysis
    • 7.5.6. Japan Sales Analysis
    • 7.5.7. South Korea Sales Analysis
    • 7.5.8. Australia Sales Analysis
    • 7.5.9. South East Asia Sales Analysis
    • 7.5.10. Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2. Latin America by Segment Sales Analysis
    • 7.6.3. Latin America by Country Sales Analysis
    • 7.6.4. Brazil Sales Analysis
    • 7.6.5. Argentina Sales Analysis
    • 7.6.6. Peru Sales Analysis
    • 7.6.7. Chile Sales Analysis
    • 7.6.8. Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2. Middle East & Africa by Segment Sales Analysis
    • 7.7.3. Middle East & Africa by Country Sales Analysis
    • 7.7.4. Saudi Arabia Sales Analysis
    • 7.7.5. UAE Sales Analysis
    • 7.7.6. Israel Sales Analysis
    • 7.7.7. South Africa Sales Analysis
    • 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE DERMATOLOGY CRO COMPANIES

  • 8.1. Dermatology Cro Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9 . COMPANY PROFILES OF DERMATOLOGY CRO INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. IQVIA Inc.
    • 9.3.1. Company Overview
    • 9.3.2. Company Revenue
    • 9.3.3. Products
    • 9.3.4. Recent Developments
  • 9.4. Labcorp Drug Development
    • 9.4.1. Company Overview
    • 9.4.2. Company Revenue
    • 9.4.3. Products
    • 9.4.4. Recent Developments
  • 9.5. Pharmaceutical Product Development LLC (PPD) (Thermo Fisher Scientific Inc.)
    • 9.5.1. Company Overview
    • 9.5.2. Company Revenue
    • 9.5.3. Products
    • 9.5.4. Recent Developments
  • 9.6. Parexel International Corp.
    • 9.6.1. Company Overview
    • 9.6.2. Company Revenue
    • 9.6.3. Products
    • 9.6.4. Recent Developments
  • 9.7. Charles River Laboratories
    • 9.7.1. Company Overview
    • 9.7.2. Company Revenue
    • 9.7.3. Products
    • 9.7.4. Recent Developments
  • 9.8. Icon PLC
    • 9.8.1. Company Overview
    • 9.8.2. Company Revenue
    • 9.8.3. Products
    • 9.8.4. Recent Developments
  • 9.9. Medidata
    • 9.9.1. Company Overview
    • 9.9.2. Company Revenue
    • 9.9.3. Products
    • 9.9.4. Recent Developments
  • 9.10. Syneos Health
    • 9.10.1. Company Overview
    • 9.10.2. Company Revenue
    • 9.10.3. Products
    • 9.10.4. Recent Developments
  • 9.11. Pharmaron
    • 9.11.1. Company Overview
    • 9.11.2. Company Revenue
    • 9.11.3. Products
    • 9.11.4. Recent Developments
  • 9.12. ragen Life Sciences Ltd.
    • 9.12.1. Company Overview
    • 9.12.2. Company Revenue
    • 9.12.3. Products
    • 9.12.4. Recent Developments
  • 9.13. Wuxi AppTec
    • 9.13.1. Company Overview
    • 9.13.2. Company Revenue
    • 9.13.3. Products
    • 9.13.4. Recent Developments
  • 9.14. MEDPACE
    • 9.14.1. Company Overview
    • 9.14.2. Company Revenue
    • 9.14.3. Products
    • 9.14.4. Recent Developments
  • 9.15. CTI Clinical Trial & Consulting
    • 9.15.1. Company Overview
    • 9.15.2. Company Revenue
    • 9.15.3. Products
    • 9.15.4. Recent Developments
  • 9.16. Bioskin
    • 9.16.1. Company Overview
    • 9.16.2. Company Revenue
    • 9.16.3. Products
    • 9.16.4. Recent Developments
  • 9.17. Proinnovera GmbH
    • 9.17.1. Company Overview
    • 9.17.2. Company Revenue
    • 9.17.3. Products
    • 9.17.4. Recent Developments
  • 9.18. Biorasi LLC
    • 9.18.1. Company Overview
    • 9.18.2. Company Revenue
    • 9.18.3. Products
    • 9.18.4. Recent Developments
  • 9.19. Javara
    • 9.19.1. Company Overview
    • 9.19.2. Company Revenue
    • 9.19.3. Products
    • 9.19.4. Recent Developments
  • 9.20. TFS
    • 9.20.1. Company Overview
    • 9.20.2. Company Revenue
    • 9.20.3. Products
    • 9.20.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies